On March 3, 2025, the Staff of the SEC Division of Corporation Finance expanded the categories of issuer that may submit draft registration ...

KP Tissue, Target and more companies all reported earnings this week. Here are the details for Canadian investors.

The “off-the-shelf” CAR T-cell therapy CTD402 will be evaluated in a phase 1b/2 trial for patients with T-cell acute ...

Back for a limited-time only, M&M's Easter Sundae White Chocolate & Dark Chocolate Easter Candy have reportedly just started ...

Principal Financial Group Inc. boosted its position in shares of B&G Foods, Inc. (NYSE:BGS – Free Report) by 2.9% during the ...

U.S. President Donald Trump’s long-threatened tariffs are here — plunging America into an escalating trade war with China, ...

Sales and profits slipped for Target during the crucial holiday quarter as customers held back on spending, and the company ...

For the year ending December 31, 2025, Nayax expects revenue growth of between 30% to 35% representing a revenue range of $410 million to $425 million on a constant currency basis. This includes ...

RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the RedChip Small Stocks, Big Money™ show, a sponsored ...

Target is facing another lawsuit, this time from brought by Florida, over a marketing decision that created intense backlash ...

Allogene Therapeutics is developing allogeneic CAR-T cells for cancer and autoimmune diseases. Read why I'm bullish on ALLO ...

Owala's newest Target-exclusive water bottles include three new colors with Joanna Gaines’ Hearth & Hand by Magnolia line and ...